Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Open in API
Filings indexed 2,557 across all filing types
Latest filing 2007-09-11 Capital/Financing Update
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Appendix 3B 7 pages ?Kb
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and references specific ASX rules (2.7, 3.10.3, 3.10.4, 3.10.5). It details the issuance of new ordinary shares and performance rights, including the number of securities issued, issue price, purpose, and quotation application. The document includes a quotation agreement with ASX and warranties related to the securities issuance. There are no financial statements, management discussion, or earnings data present. The document is a formal announcement of a new securities issue and application for quotation rather than a full financial report or earnings release. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2007-09-11 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new ordinary shares, including the number of securities issued, issue price, purpose, and quotation application to the ASX. It references specific ASX rules and includes a quotation agreement section. The content is focused on announcing and providing details about a new share issue and the application for quotation of these securities on the ASX. There are no financial statements, management discussion, or audit information present. The document is a regulatory announcement related to capital raising and share issuance, fitting the category of Capital/Financing Update (CAP).
2007-09-06 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new ordinary shares by CSL Limited, including the number of securities issued, terms, issue price, purpose, and quotation application to the ASX. It references ASX rules and compliance warranties related to the new securities issuance. The content is focused on announcing and providing regulatory details for a new share issue and application for quotation, rather than presenting financial results, management discussion, or other report types. The document length is about 10,941 characters, which is consistent with a detailed announcement rather than a full financial report. Therefore, this document fits the category of a Share Issue/Capital Change announcement.
2007-09-04 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new ordinary shares, including number of shares, issue price, terms, and quotation application to the ASX. It references specific ASX rules and includes sections on securities ranking, issue price, purpose, and quotation agreement. The content is consistent with a formal announcement of new share issuance and application for quotation rather than a full financial report or earnings release. The document length is over 11,000 characters, indicating it is a substantive announcement rather than a brief notice. This matches the definition of a Share Issue/Capital Change announcement (SHA).
2007-09-02 English
Appendix 3Y x 7 14 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in directors' relevant interests in securities, including the number of shares held before and after the change, dates of changes, and consideration paid. The document is a formal notification of insider share transactions by company directors. It does not contain financial statements, management discussion, or other report content. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is substantial and contains multiple such notices for different directors, reinforcing that it is a comprehensive insider trading report rather than a brief announcement or other filing type.
2007-08-29 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new ordinary shares by CSL Limited, including the number of securities issued, issue price, terms, and application for quotation on the ASX. It references ASX rules and compliance warranties related to the quotation of securities. The content is focused on announcing and providing details of a new share issue and the application for quotation of these securities on the stock exchange. There are no financial statements, management discussion, or earnings data present. The document is a formal announcement of a capital raising event and related securities quotation, fitting the definition of a Capital/Financing Update (CAP).
2007-08-26 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.